- CNBC•13 hours ago
Jim Cramer rattled off his take on caller favorite stocks, including defense contractor Raytheon.
- Motley Fool•17 hours ago
AstraZeneca, Bristol-Myers Squibb, and Pfizer receive good news from the real world.
- Zacks•20 hours ago
Pfizer, Inc.'s (PFE) rheumatoid arthritis (RA) drug, Xeljanz has received marketing approval in Europe.
PFE : Summary for Pfizer, Inc. - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||34.05 x 100|
|Ask||34.21 x 900|
|Day's Range||33.97 - 34.26|
|52 Week Range||29.41 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.12|
|Dividend & Yield||1.28 (3.74%)|
|1y Target Est||N/A|